Covestor’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2
Closed 2298
2025
Q4
$0 Hold
2
﹤0.01% 2297
2025
Q3
$0 Hold
2
﹤0.01% 2317
2025
Q2
$0 Hold
2
﹤0.01% 2243
2025
Q1
$0 Hold
2
﹤0.01% 2257
2024
Q4
$0 Sell
2
-343
-99% -$13.1K ﹤0.01% 2267
2024
Q3
$11K Buy
345
+344
+34,400% +$19.1K 0.01% 1481
2024
Q2
$0 Hold
1
﹤0.01% 2265
2024
Q1
$0 Hold
1
﹤0.01% 2268
2023
Q4
$0 Sell
1
-1
-50% -$102 ﹤0.01% 2174
2023
Q3
$0 Hold
2
﹤0.01% 2148
2023
Q2
$0 Hold
2
﹤0.01% 2161
2023
Q1
$0 Buy
2
+1
+100% +$52 ﹤0.01% 2060
2022
Q4
$0 Hold
1
﹤0.01% 2099
2022
Q3
$0 Buy
+1
New +$142 ﹤0.01% 2034
2022
Q2
Sell
-1
Closed -$335 1946
2022
Q1
$0 Hold
1
﹤0.01% 2132
2021
Q4
$0 Buy
+1
New +$764 ﹤0.01% 2127

Other funds holding CDLX

Covestor's CDLX Position: Q1 2026 in Review

Covestor sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 2 shares.

Covestor first reported a position in CDLX in Q4 2021 and held it in 16 quarters. The position peaked at $11K in Q3 2024. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Covestor reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • Covestor sold 2 Cardlytics shares in Q1 2026.
  • Covestor first reported a position in Cardlytics in Q4 2021 and held it in 16 quarters.
  • Covestor's Cardlytics position peaked at $11K in Q3 2024.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.